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Abstract
How dietary restriction (DR) increases lifespan and decreases disease burden are questions of major interest in biomedical
research. Here we report that hypothalamic expression of CREB-binding protein (CBP) and CBP-binding partner Special AT-rich
sequence binding protein 1 (SATB-1) is highly correlated with lifespan across five strains of mice, and expression of these genes
decreases with age and diabetes in mice. Furthermore, in Caenorhabditis elegans, cbp-1 is induced by bacterial dilution DR (bDR)
and the daf-2 mutation, and cbp-1 RNAi specifically in adults completely blocks lifespan extension by three distinct protocols of
DR, partially blocks lifespanextension by the daf-2mutation butnotofcold,andblocksdelayofotherage-relatedpathologiesby
bDR. Inhibiting the C. elegans ortholog of SATB-1and CBP-binding partners daf-16 andhsf-1alsoattenuateslifespanextension by
bDR, but not other protocols of DR. In a transgenic Ab42 model of Alzheimer’s disease, cbp-1 RNAi prevents protective effects of
bDR and accelerates Ab42-related pathology. Furthermore, consistent with the function of CBP as a histone acetyltransferase,
drugs that enhance histone acetylation increase lifespan and reduce Ab42-related pathology, protective effects completely
blocked by cbp-1 RNAi. Other factors implicated in lifespan extension are also CBP-binding partners, suggesting that CBP
constitutes a common factor in the modulation of lifespan and disease burden by DR and the insulin/IGF1 signaling pathway.
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Introduction
Elucidation of mechanisms mediating lifespan extension and
reduction of disease burden, including cancer and neurodegenerative
diseases, by DR is a major goal of aging research [1]. Recent studies
have implicated sirtuins [2], SKN-1 [3], SMK-1 and PHA-4/Foxa
[4], AMPK [5], RHEB-1 [6], daf-16/Fox1a [5], and HSF-1 [7] in
mediating lifespan extension by some, but not all [8,9], protocols of
DR in Caenorhabditis elegans. However, a role for expression of these
genes in mammalian lifespan has not been addressed, nor, with rare
exceptions [7], has a role for expression of these genes in reduction of
age-related pathologies by DR. The purpose of the present studies
was to discover genes whose expression predicts lifespan and whose
expression decreases with age and disease in mammals, whose
expression is induced by DR, and whose inhibition attenuates life
extension by several distinct protocols of DR. We report that among
genes implicated in lifespan extension by DR or the insulin-like
signaling pathway, only CBP meets these criteria.
Results
Expression of CBP and SATB-1 Predicts Lifespan and
Decreases With Age and Diabetes in Mice
Since hypothalamic neurons mediate physiological responses to
nutritional deprivation, we hypothesized that hypothalamic gene
expression may play a role in mediating lifespan extension by DR
[10], a hypothesis supported by the observation that two neurons
mediate protective effects of DR in C. elegans [3]. In a small
microarray survey to discover candidates that may mediate
protective effects of DR, the only transcription factor we
corroborated to be induced by nutritional deprivation in mouse
hypothalamus was the transcription factor CBP/p300-interacting
transactivator with Glu/Asp-rich carboxy-terminal domain 1
(CITED-1) [11]. In a larger microarray survey, we observed over
40 transcription factors induced by nutritional deprivation in
mouse hypothalamus, among the most prominent of which were
CBP and its co-factors.
Hypothesizing that expression of genes mediating lifespan
extension by DR may also predict lifespan under ad lib fed
conditions, we screened over 40 genes, including CBP and genes
otherwise implicated in lifespan extension, to detect genes whose
hypothalamic expression predicts lifespan across five strains of
mice (BALB/cByJ, A/J, C3H/HeJ, DBA/2J, and C57Bl/6J) in
order of increasing lifespan, based on published lifespan data (see
Methods) [12,13]. Hypothalamic expression of CBP and SATB1
were highly and positively correlated with lifespan (Figure 1A and
1B), accounting for 84% and 81%, respectively, of lifespan
variance. These results were corroborated in a second set of mice
purchased over 2 y after the first strain comparison study, with
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other genes implicated in aging, including mammalian orthologs
to sirtuins, daf-16/FoxO3a, pha-4/FoxA, rheb-1, hsf-1, skn-1/NFE2,
hif-1, and aak-2/ampk, did not correlate significantly with lifespan.
Similarly, cortical expression of CBP, SATB-1, and HSF-1 but not
other genes implicated in influencing lifespan (e.g., the daf-16
ortholog FOXO3A) decreased with age and diabetes, a disease
that mimics many effects of aging (Figure 1C) [14].
To address the functional role of these genes in determining
senescent phenotypes using RNA interference (RNAi), we
extended these studies to C. elegans. Expression of cbp-1, the C.
elegans ortholog of mammalian CBP [15], was induced in C. elegans
by both DR (produced by dilution of bacteria to optimize lifespan
[8] bDR) and mutation of the insulin-like receptor (daf-2)
(Figure 1D, 1E, 1F). Furthermore, cbp-1 RNAi completely blocked
induction of the gene by bacterial dilution and reduced cbp-1
expression to about half the level of the ad lib bacterial
concentration (Figure 1D); the inhibition was similar at both ad
lib and diluted bacterial concentrations (Figure 1D). In contrast to
mouse hypothalamus, we did not observe decreased expression of
cbp-1 in whole C. elegans during aging.
cbp-1 RNAi Completely Blocks Lifespan Extension by
Three Protocols of DR in C. elegans
Three classes of protocols for DR have been used to extend
lifespan in C. elegans: ‘‘axenic’’ or ‘‘dietary deprivation’’ dietary
restriction with no bacteria [16,17,5], genetic reduction of feeding
rate (e.g., by mutation in the eat-2 gene [18]), or optimized bacterial
dilution in liquid media (bDR) [19,3,8]. Lifespan extension by
different DR protocols requires different sets of genes [9], although
it has been argued that the optimized bacterial dilution method
provides the most valid protocol [3,8]. We therefore used one
protocol from each class of DR to assess the role of cbp-1 in lifespan
extension by DR. First, entailing axenic liquid media, worms were
maintained on standard solid agar plates in which bacteria (RNAi-
bearing or control) were present on adult days 1–5, then transferred
to liquid axenic media with no bacteria for the remainder of the
study [16]. This protocol produces lifetime inhibition of the target
gene (unpublished data), but to our knowledge no genes have
previously been implicated in lifespan extension by axenic media
[9]. Second, worms expressing the eat-2 mutation were maintained
on standard solid media with bacteria; extension of lifespan by this
protocol requires the activity of several genes implicated in aging
including hsf-1 but not daf-16/foxO3a or aak-2/ampk [9]. Finally,
worms were maintained in liquid media in which bacteria were
diluted for optimum lifespan (bDR) [19,3,8]. The bacterial dilution
producing the greatest average lifespan was determined by serial
bacterial dilution, and the optimum concentration for longest
lifespan was 10ˆ9 bacteria/ml (Figure S1), similar to the optimum
concentration previously reported [19]. Two other bacteria
concentrations, 10ˆ8a n d1 0 ˆ10 cells/ml, both of which reduced
lifespan compared to 10ˆ9 cells/ml (Figure S1), were used for
comparison. In all studies worms were fed bacteria expressing
control (L4440) or dsRNAi constructs in the adult phase only. The
RNAi-sensitive rrf-3 strain [20] used in some of these studies
exhibited the same average lifespan and lifespan extension as
exhibited in the control N2 strain (Table S1).
The axenic media protocol increased average lifespan in worms
fed control bacteria by about 50%, an extension of lifespan
completely blocked by cbp-1 RNAi (Figure 2A, Table S1). The eat-
2 mutation increased lifespan by about 20%, an extension also
completely blocked by cbp-1 RNAi (Figure 2B, Table S1). At the
optimum bacterial concentration (10ˆ9 bacteria/ml), lifespan
increased by about 65% relative to ad lib concentration (10ˆ10)
bacteria/ml, an extension also completely blocked by cbp-1 RNAi
(Figure 2C, Table S1). Thus, inhibiting cbp-1 by only 50%
specifically in the adult phase (Figure 1D) completely blocked
lifespan extension by three distinct protocols of DR.
To assess the specificity of the reversal of DR-induced lifespan
extension by cbp-1 RNAi, we assessed if cbp-1 RNAi, like daf-16
RNAi, would block lifespan extension by the daf-2 mutation.
Under standard conditions the daf-2 mutation increased average
lifespan by 157% (Figure 2D, Table S1), consistent with previous
reports [21]. While in contrast to DR cbp-1 RNAi did not
completely block lifespan extension by the daf-2 mutation, it did
substantially reduce the degree of lifespan extension by the daf-2
mutation (Figure 2D, Table S1). While daf-16 RNAi and cbp-1
RNAi reduced average lifespan in ad lib conditions to about the
same extent, cbp-1 RNAi completely blocked lifespan extension by
bDR on lifespan but only partially blocked lifespan extension by
the daf-2 mutation at the ad lib concentration. Conversely, daf-16
RNAi completely blocked lifespan extension by the daf-2 mutation
but only partially blocked lifespan extension by bDR (Figure 2D,
Table S1). Furthermore, whereas at the ad lib bacterial
concentration in liquid media the daf-2 mutation increased
lifespan by about 30% and optimum bacterial dilution increased
lifespan by 65%, the daf-2 mutation further increased lifespan at
the optimum bacterial concentration by 40% (Figure 2E, Table
S1), consistent with previous conclusions that lifespan extension by
the daf-2 pathway and by DR are mediated by additive
mechanisms [19]. Nevertheless, cbp-1 RNAi completely blocked
the increase in lifespan by the daf-2 mutation at the optimum
bacterial concentration (Figure 2E, Table S1), suggesting that
under conditions of bDR cbp-1 may participate in lifespan
extension by the daf-2 mutation. Similarly, cbp-1 RNAi completely
blocked lifespan extension by the glp-1 and clk-1 mutations (Table
S1), the latter observation consistent with a key role of electron
chain transport complex I in mediating effects of DR on lifespan
[14].
Although both cbp-1 RNAi and daf-16 RNAi slightly reduced
lifespan under standard conditions, and to the same extent (as is
Author Summary
The simple manipulation of dietary restriction (DR)
(reduction of caloric intake by about 30% in rodents)
produces robust increases in lifespan and slows the
development of almost all age-related diseases, including
cancer and neurological diseases. This relationship be-
tween dietary restriction and longevity is observed in most
models in which the effect of DR has been tested. Thus,
understanding how DR produces its protective mecha-
nisms would have potentially profound implications for
the treatment of age-related diseases, including possibly
the development of a ‘‘magic bullet’’ for these diseases. In
the present study we have discovered that DR induces a
transcription factor, CBP, and additional factors that work
with CBP to control the expression of other genes involved
in determination of lifespan. When we blocked the DR-
mediated increase in CBP and associated factors, we
blocked all the protective effects of DR on lifespan
extension, on the slowed rate of aging, and on protection
against pathology in a model of Alzheimer’s disease.
Further, in mice expression of CBP and a CBP-interacting
factor positively predicted lifespan, and expression of both
factors decreased with age and in diabetes. Finally,
pharmacological manipulations that mimicked enhanced
CBP activity increased lifespan and reduced pathology in a
model of Alzheimer’s disease.
CBP and SATB-1 in Aging, DR, and IIS
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hsf-1 and dve-1/satb-1 RNAi; see below), the effect on mortality was
only manifested late in life, indicating that increased mortality by
cbp-1 RNAi is specific to the aging process. Furthermore, cbp-1
RNAi did not attenuate lifespan extension by low temperature
(40% extension in controls vs. 44% extension in the cbp-1 RNAi
group) (Figure 2F). Similarly, cbp-1 RNAi had no effect on lifespan
in daf-16 hypomorphic (m26) worms (Figure 2G and Table S1),
and combining both cbp-1 and daf-16 RNAi in wild-type N2
worms produced a similar reduction in lifespan as produced by
either cbp-1 or daf-16 RNAi alone (Table S1). Taken together,
these studies demonstrate that lifespan reduction by cbp-1 RNAi is
not non-specific but depends on context, such that increased
mortality due to cbp-1 RNAi depends on age and daf-16, is greatest
under conditions of dietary restriction, and is minimal under ad lib
fed conditions.
Figure 1. Expression of CBP and SATB-1 predicts lifespan, is reduced with aging and diabetes, and is induced by DR and the Daf-2
mutation. Hypothalamic mRNA, assessed by q-PCR, of (A) cbp (n=10/group, p=0.027, R
2=84%) and (B) satb-1 (n=10/group, p=0.036, R
2=81%)
correlates with average lifespan across five mouse strains (BALB/cByJ, A/J, C3H/HeJ, DBA/2J, and C57Bl/6J, in order of increasing lifespan). (C) Cortical
mRNA of CBP, SATB-1, HSF-1, and FOXO3A in young (10–12 wk), aged (18–19 mo), and diabetic male C57Bl/6J mice. Data are presented as mean 6
SEM (n=7–14/group, *p,0.05). cbp-1 mRNA is (D) induced by bDR (10 ˆ9 bacteria/ml) and inhibited by cbp-1 RNAi, and (E) induced by the daf-2
hypomorphic allele. (F) CBP-1 protein, assessed by immunoblotting, is induced by DR (10 ˆ9 bacteria/ml) and the daf-2 mutation.
doi:10.1371/journal.pbio.1000245.g001
CBP and SATB-1 in Aging, DR, and IIS
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To more directly assess the impact of cbp-1 on the rate of aging,
we quantified the effect of cbp-1 RNAi on mortality rate doubling
time, using the Gompertz model for mortality rate, h(t)=Ae
Gt,i n
which G reflects age-dependent acceleration of mortality rate and
thus the rate of aging, whereas A reflects the initial or constant
component of mortality rate [23]. The effect of bDR and cbp-1
RNAi were calculated using an improved and validated algorithm,
based on a validated non-linear regression algorithm, as recently
described [24]. Based on these analyses, bDR significantly reduced
Figure 2. Cbp-1 RNAi blocks life extension by DR produced by three protocols. (A) Axenic media; adult rrf3 worms were fed bacteria
expressing control L4440 or cbp-1 dsRNA for 5 d, then transferred to liquid axenic media. (B) eat-2 mutation; adult eat-2 mutant worms (ad1113) were
fed bacteria expressing control L4440 or cbp-1 dsRNA. (C) Bacterial dilution (bDR); adult worms were grown in liquid media at three concentrations of
bacteria expressing control L4440 or cbp-1 dsRNA. (D) daf-2 mutant or wild-type worms under standard conditions were fed bacteria expressing
control L4440 or cbp-1 dsRNA (cbp-1 RNAi only partly blocks lifespan extension by the daf-2 mutation; p,0.05). (E) daf-2 mutant worms under
optimum bacterial concentration (bDR) were fed bacteria expressing control L4440 or cbp-1 dsRNA (cbp-1 RNAi blocks lifespan extension by the both
bDR and the daf-2 mutation in these conditions). (F) Cold-induced longevity; adult worms were maintained under standard conditions at either 25 C
or 16 C and fed bacteria expressing control L4440 or cbp-1 dsRNA (40% extension in controls versus 44% extension in the cbp-1 RNAi group; effect
not significant). (G) cbp-1 or control RNAi in daf-16 hypomorphic worms (effect not significant).
doi:10.1371/journal.pbio.1000245.g002
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RNAi significantly accelerated the rate of aging; Figure 3A and
Table S2). By the same analysis, the daf-2 mutation also
significantly reduced the rate of aging, an effect similarly (though
only partly) reversed both by cbp-1 RNAi and daf-16 RNAi
(Figure 3B and Table S2). Another marker thought to reflect a
fundamental process of aging, sensitivity to oxidative stress [25], as
indicated by paraquat-induced mortality, was delayed by bDR
Figure 3. Cbp-1 RNAi accelerates aging without producing non-specific toxicity. cbp-1 RNAi reverses the reduction of mortality rate
doubling time by (A) DR or (B) the daf-2 mutation. The Gompertz variables G and A were calculated using non-linear regression on the Kaplan-Meier
estimates of the survivorship curves. Line was generated from the calculated value of G (slope) and A (intercept). Mortality rate doubling time equals
to Ln2 divided by G. cbp-1 RNAi reverses resistance to 50 mM paraquat produced by (C) bDR or the (D) daf-2 mutation. Data are quantified as average
survival time in the paraquat solution and presented as mean 6 SEM (n=30/group, *p,0.01, **p,0.001). (E) cbp-1 RNAi accelerates paralysis caused
by age-dependent aggregation of transgenic human Ab1-42. Data are quantified as average rate of paralysis per day and presented as mean 6 SEM
(n=50–100/group). cbp-1 RNAi (F) increases autofluorescence but (G) does not reduce activity. Data are presented as mean 6 SEM (n=6–10/group,
*p,0.05).
doi:10.1371/journal.pbio.1000245.g003
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(Figure 3C and 3D).
Mechanisms by which DR increases lifespan are of interest, but
of even greater interest are mechanisms by which DR reduces the
burden of age-related pathologies, including such disparate
diseases as cancer and neurodegeneration [1]. We therefore
assessed if cbp-1 RNAi would block protective effects of bDR to
delay the development of pathology in a transgenic model of
Alzheimer’s disease produced by expression of human Ab1-42 in
C. elegans (CL2006) [7,26]. Consistent with previous reports [7],
bDR delayed the onset of paralysis produced by the human Ab1-
42 transgene, and cbp-1 RNAi greatly accelerated the onset of
paralysis (Figure 3E). However, since cbp-1 RNAi accelerated the
onset of paralysis even in worms subjected to bDR (Figure 3E),
and bDR significantly delayed the onset of paralysis even in the
presence of cbp-1 RNAi, the effect of cbp-1 RNAi on Ab1-42-
dependent pathology may be independent of bDR.
To further assess if cbp-1 RNAi reduces lifespan by accelerating
aging or producing general sickness, we examined if cbp-1 RNAi
would increase autofluroescence, an indicator of aging, or reduce
activity, an indicator of toxicity [27]. cbp-1 RNAi significantly
accelerated the accumulation of autofluorescence (Figure 3F) but
had had no effect on activity (Figure 3G), the active portion of
lifespan (65% for control versus 67% for cbp-1 RNAi), egg laying
(Figure S2), or pharyngeal pumping rate (Figure S3). Interestingly,
however, cbp-1 RNAi did reduce DiI staining in amphid neurons
Figure S4).
Inhibition of Three CBP-Interacting Factors Attenuates
Lifespan Extension by bDR
To discover genes mediating lifespan extension by bDR, we
used RNAi to screen over 500 genes including factors that interact
with CBP, are nutritionally regulated, or are otherwise reported to
influence lifespan, for reduction of lifespan at the optimal bacterial
concentration (see Methods). In this screen inhibition of only four
genes reduced viability on adult day 20 at the optimum bacterial
concentration: cbp-1, daf-16, hsf-1, and dve-1 (Defective proVEn-
triculus in Drosophila), the C. elegans ortholog of satb-1. More
detailed lifespan studies corroborated that hsf-1, daf-16, and dve-1
attenuated lifespan extension by bDR, though daf-16 RNAi and
dve-1 RNAi did not completely block lifespan extension by bDR
(Table S1), whereas cbp-1 and hsf-1 RNAi did completely block
lifespan extension by bDR (Table S1). Furthermore, daf-16 RNAi
also completely blocked lifespan extension by the daf-2 mutation as
previously reported [28], while hsf-1, dve-1, and cbp-1 RNAi only
partially blocked life extension by the daf-2 mutation (Figure 4B).
As with cbp-1, RNAi directed against all of these other three gene
products attenuated protection against oxidative stress by bDR
(Figure 4C).
Cbp-1 RNAi Blocks Effects of bDR on Expression of Genes
Regulated by daf-16 and hsf-1 and Other Genes
Regulating Metabolism
Mammalian FOXO3A [29], HSF-1 [30], and SATB-1 [31] all
interact with CBP. In C. elegans, the interaction between DAF-16
and CBP-1 has been confirmed by yeast two-hybrid assays [29].
To assess possible interactions between C. elegans cbp-1 and these
CBP-binding gene products, we assessed the effect of cbp-1 RNAi
on genes regulated by daf-16 and hsf-1. daf-16 and hsf-1 were
induced by bDR (Figure 4D and 4E), whereas, interestingly, dve-1
expression was not induced (unpublished data). Though cbp-1
RNAi did not block the induction of daf-16 or hsf-1 (Figure 4D and
4E) by bDR, it did block the induction of the DAF-16 target gene,
sod-3 [32], and the HSF-1 target gene, sip-1 [28] by bDR
(Figure 4F and 4G). cbp-1 RNAi also blocked the induction of sod-3
expression by daf-2 RNAi (Figure S5). In contrast, cbp-1 RNAi did
not block increased Nile Red staining produced by the daf-2
mutation, and in fact further enhanced Nile Red staining in daf-2
mutant worms (Figure S7).
We also assessed the effects of bDR and cbp-1 RNAi on 17 genes
regulating glycolysis and beta-oxidation of lipids (based on their
regulation by nutritional deprivation [33]), since the shift away
from glycolysis toward beta-oxidation may contribute to protective
effects of DR to increase lifespan and decrease disease burden
[14]. As expected [14,33], DR shifted metabolic balance away
from glycolysis and toward beta-oxidation, as indicated by
inhibited expression of Y71H10A.1, an ortholog of mammalian
PFK, and F47G4.3, an ortholog of mammalian glycerophosphate
dehydrogenase, and induced expression of ZK370.5, an ortholog
of pyruvate dehydrogenase kinase (Figures 4H, S8, and S9), and
W03F9.4, an ortholog of mammalian CPT1 (Figure 4I), as well as
genes promoting peroxisome metabolism (unpublished data). As
with genes regulated by daf-16 and hsf-1, cbp-1 RNAi blocked the
effect of bDR on every metabolic gene whose expression was
influenced by bDR (Figures 4D, 4E, 4F, 4G, 4H, 4I, S8, and S9).
Age-Related Decrease in Histone Acetylation Level Is
Delayed by bDR and Accelerated by cbp-1 RNAi
As a histone acetyltrasferase (HAT), CBP acetylates core
histones and transcription factors [34], in particular histone H4
at lysine 5 [35]. To assess the relationship of HAT activity to
lifespan, we examined acetylation of H4 Lys 5 during aging, and
with bDR and cbp-1 RNAi. Acetylation of H4 Lys 5, but not total
H4, decreased with age (Figure 5A) and with cbp-1 RNAi
(Figure 5B) and increased with DR (Figure 5C).
HDAC Inhibitors Increase Lifespan Dependent on cbp-1
and Delay Ab1-42-Dependent Paralysis
To assess if mimicking HAT activity chemically mimics
protective effects of DR, we examined if two HDAC inhibitors,
sodium butyrate (NaB) and Trichostatin A (TSA), would increase
lifespan and reduce paralysis produced by the Ab1-42 transgene.
Both HDAC inhibitors increased H4 Lys 5 acetylation (Figure 5D)
and significantly increased lifespan at both ad lib and optimal
bacterial concentrations, protective effects completely prevented
by cbp-1 RNAi (Figure 5E, 5F, and 5G, and Table S1). Similarly
both HDAC inhibitors significantly delayed the onset of paralysis
produced by the Ab1-42 transgene (Figure 5H).
Discussion
In the present studies, we used two complementary screens to
discover genes implicated in lifespan: an expression screen to
discover genes whose hypothalamic expression predicts lifespan
across five strains of mice, and an RNAi screen to discover genes
whose inhibition blocks life extension by bDR. In the expression
screen, hypothalamic expression of CBP and SATB-1, but not
other genes previously implicated in influencing lifespan [2–9],
correlated positively with lifespan. Since it is unlikely that
polymorphisms in any single gene could account for such a large
degree of variance in lifespan [36], we hypothesize that the
differential hypothalamic expression of CBP and SATB-1 across
strains is a quantitative trait reflecting many polymorphisms,
which however sum to produce genetic variance in lifespan. It is
not yet clear if the differential expression of CBP and SATB-1 that
correlates with lifespan is confined to the hypothalamus, but cbp-1
RNAi does produce dye-filling defects in all C. elegans amphid
CBP and SATB-1 in Aging, DR, and IIS
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consistent with the observation that a small number of neurons
mediates lifespan extension by DR [3]. The identity of
hypothalamic neurons whose expression of CBP predicts lifespan
is therefore of particular interest.
Similarly, among genes whose expression was examined
(including those previously implicated in mediating protective
effects of DR), expression of only CBP, SATB-1, and HSF-1
decrease with age and diabetes. In the initial RNAi screen in C.
elegans, of over 500 genes potentially associated with CBP or
Figure 4. Inhibition of CBP-interacting factors attenuates lifespan extension by bDR. (A) daf-16,hsf-1,a n ddve-1 RNAi attenuate lifespanextension
by bDR. (B) daf-16 and hsf-1 but not dve-1 RNAi blocks lifespan extension by the daf-2 mutation. (C) daf-16, hsf-1,a n ddve-1 RNAi decreases resistance to
50 mM paraquat. bDR induces expression of (D) daf-16 and (E) hsf-1,b u tcbp-1 RNAi does not block this induction. However, cbp-1 RNAi blocks induction of
(F), sod-3,( G )sip-1, and (I) W03F9.4/CPT-1 and inhibition of (H) Y71H10A.1 by bDR. Data are presented as mean 6 SEM (n=4–6/group,*p,0.05).
doi:10.1371/journal.pbio.1000245.g004
CBP and SATB-1 in Aging, DR, and IIS
PLoS Biology | www.plosbiology.org 7 November 2009 | Volume 7 | Issue 11 | e1000245CBP and SATB-1 in Aging, DR, and IIS
PLoS Biology | www.plosbiology.org 8 November 2009 | Volume 7 | Issue 11 | e1000245otherwise implicated in mediating effects of DR, only four genes
were implicated in subsequent detailed analysis of lifespan
extension by bDR: cbp-1, daf-16, hsf-1, and dve-1, the C. elegans
ortholog of SATB-1. It should be noted, however, that whereas
cbp-1 and hsf-1 RNAi completely block lifespan extension by bDR,
daf-16 and dve-1 RNAi only partially block lifespan extension by
bDR. Since molecular mechanisms mediating DR depend on the
protocol of DR [8,9], we further corroborated that cbp-1 RNAi
blocks lifespan extension by the eat-2 mutation and liquid axenic
media. To our knowledge cbp-1 is the only gene implicated in
lifespan extension by three different protocols of DR; it will
therefore be of interest to determine if there are any protocols of
DR in which life extension is not blocked by cbp-1 RNAi [9].
Of the more than 500 genes screened in two distinct protocols,
the gene most comprehensively implicated in mediating lifespan
extension by bDR was cbp: expression of CBP accounts for the most
variance in lifespan, decreases with age and diabetes, is induced by
bDR and by the daf-2 mutation, and cbp-1 RNAi blocks lifespan
extension by all three protocols of DR examined so far and partly
attenuates lifespan extension by the daf-2 mutation. Expression of
SATB-1 accounts for almost as much variance of lifespan and
decreases with age and diabetes but is not induced by bDR, and dve-
1 RNAi (ortholog of SATB-1) only partly blocks lifespan extension
by bDR and the daf-2 mutation. Expression of HSF-1 decreases
with age and diabetes and is induced by bDR, and hsf-1 RNAi
completely blocks lifespan extension by bDRand the daf-2 mutation
but does not block lifespan extension by other protocols of DR [8],
nor predicts lifespan. Expression of daf-16 is induced by bDR, and
daf-16 RNAi completely blocks lifespan extension by the daf-2
mutation, but only partially blocks lifespan extension by bDR and
does not attenuate lifespan extension by other protocols of DR [8],
nor does expression of FOX03A predict lifespan or decrease with
age or diabetes. Nevertheless, since cbp-1 RNAi greatly suppresses
lifespan extension by the daf-2 mutation (completely so under bDR
conditions), we hypothesize that cpb-1 also plays a role in mediating
effects of the insulin/IGF1 signaling pathway on longevity, possibly
through an interaction with daf-16 [29].
The robustness with which cbp-1 RNAi blocks lifespan extension
by DR, and the observation that cbp-1 RNAi slightly reduces
lifespan in standard conditions, raises the key question of whether
cbp-1 RNAi reduces lifespan extension by DR by reversing the
retardation of aging by DR or by increasing general sickness [27].
Several lines of evidence strongly support that cbp-1 RNAi
specifically acts by reversing effects of DR on the process of
aging. First, it should be noted that cbp-1, daf-16 and hsf-1 RNAi,
and pha-4 hypomorphism [4] reduce lifespan in standard
conditions to the same extent, and it is accepted that these latter
genes influence lifespan by influencing the process of aging, not by
increasing general sickness [4,28]. As with pha-4, daf-16, and hsf-1
RNAi, the effect of cbp-1 RNAi to increase mortality in standard
conditions is completely age-dependent, occurring only after
midlife, and entails a doubling of the age-dependent acceleration
of mortality rate without influencing initial mortality rate,
inconsistent with age-independent general sickness. Furthermore,
the effect of cbp-1 RNAi on lifespan is highly context-dependent,
reducing lifespan maximally in the context of DR (any of three
protocols), partially in long-lived daf-2 mutant worms, minimally in
standard conditions, and not at all in daf-16 mutant worms.
Conversely, daf-16 RNAi, which reduces lifespan in standard
conditions to the same extent as does cbp-1 RNAi, reduces lifespan
maximally in long-lived daf-2 mutant worms and only partly
reduces lifespan in the context of DR [18,4]. Thus the same logic
that supports the conclusion that daf-16 and hsf-1 mediate lifespan
extension by the daf-2 mutation, and that pha-4 mediates lifespan
extension by bDR, would also appear to support the conclusion
that cbp-1 also mediates lifespan extension by bDR. Furthermore,
cbp-1 RNAi specifically blocks effects of bDR on parameters
thought to reflect processes of aging, age-dependent acceleration
of mortality rate, resistance to oxidative stress, and specific profile
of metabolic and anti-oxidant gene expression. Similarly, cbp-1
RNAi accelerates the onset of autofluorescence without reducing
total activity, feeding activity, or egg-laying rate, thus meeting
criteria previously described for processes specifically impinging on
aging rather than general sickness [27]. Indeed, cbp-1 has been
implicated in a genome-wide RNAi screen as one of 41 genes
potentially mediating life extension through the insulin/IGF1
signaling pathway by influencing the process of aging, not general
sickness [27]. Of particular interest, bDR delays and cbp-1 RNAi
accelerates the onset of proteotoxicity, just as the daf-2 mutation
and DR delay, and inhibition of daf-16 and hsf-1 accelerates, the
same toxicity [7,28]. Taken together, these data strongly support
that cbp-1 mediates lifespan extension and reduction of age-related
pathology by DR.
Mechanisms linking cbp-1 expression to increased lifespan and
reduced age-related pathology are therefore of great interest. It is
suggestive that all genes implicated in the present screens are
either CBP or CBP-binding co-activators [29–31]. Similarly, genes
recently implicated in mediating lifespan extension by DR, skn-1
and pha-4, also code for transcriptional factors that interact with
CBP [37,38]. Furthermore, transgenic overexpression of cbp-1 did
not significantly increase lifespan (Figure S6), suggesting that
effects of CBP on lifespan requires increased expression of other
factors. Uniquely among factors implicated in mediating lifespan
extension by DR, RHEB-1 is not known to interact with CBP [6].
However, RHEB-1 mediates lifespan extension by intermittent
fasting-induced longevity [6], which, in contrast to other protocols
of DR (including those examined in the present studies), increases
lifespan by reducing initial mortality rate, not by reducing age-
related acceleration of mortality rate (Yen and Mobbs, unpub-
lished data), a characteristic of lifespan regulation through
chemosensory rather than caloric mechanisms [39]. We therefore
hypothesize that CBP-interacting transcriptional complexes
(whose composition may depend on DR protocol) mediate
protective effects of reduced caloric intake, whereas other
mechanisms mediate lifespan extension by chemosensory
mechanisms.
Figure 5. HDAC inhibitors increase histone acetylation and lifespan and delay pathology in a model of Alzheimer’s disease. (A)
Immunoblot for histone H4 and acetylated H4 (Lys5) in N2 worms during aging. Left: Immunoblot; Right: Densitometry (normalized to total H4). (B)
Immunoblot for histone H4 and acetylated H4 (Lys5) in rrf3 worms fed with control bacteria or bacteria expressing cbp-1 dsRNA. (C) Immunoblot for
histone H4 and acetylated H4 (Lys5) in N2 worms with bDR or control (ad lib) condition. (D) Immunoblot for histone H4 and acetylated H4 (Lys5) in
the N2 worms treated with or without HDAC inhibitors (5 mM NaB and 150 ng/ul TSA). Left: Immunoblot; Right: Densitometry (normalized to total
H4). (E) HDAC inhibitors (5 mM NaB and 150 ng/ul TSA) extend lifespan of N2 worms at 20uC. (F) Lifespan-extending effect of NaB is blocked by cbp-1
RNAi. N2 worms were treated with bacteria expressing cbp-1 dsRNA or control, and lifespan was measured in the presence or absence of 5 mM NaB
at 20 C. (G) NaB further extended lifespan of bDR worms. N2 worms were treated with bacteria expressing cbp-1 dsRNA or control at optimum
bacterial dilution (10ˆ9 cells/ml) at 20 C. Lifespan was measured in the presence or absence of 5 mM NaB at 20C. cbp-1 RNAi completely blocked life
extension by NaB and bDR. (H) NaB and TSA decrease Ab1-42 toxicity as measured by rate of paralysis in Ab1-42 transgenic worms (CL2006).
doi:10.1371/journal.pbio.1000245.g005
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increase lifespan and reduce age-related pathologies remains to be
fully elucidated. An important role for the protective effects of
CBP HAT activity is implicated by the observation that HDAC
inhibitors, which effectively amplify HAT activity, increase
lifespan, an effect completely dependent on cbp-1 (enhanced by
bDR, which increases CBP activity, and completely blocked by
cpb-1 RNAi). Since HAT activity, by increasing histone acetyla-
tion, presumably enhances transcriptional flexibility, decreased cbp
expression with age may contribute to age-related loss of adaptive
capacity [40], in particular in learning and memory [41]. On the
other hand, HDAC inhibitors increase lifespan less than does
dietary restriction, suggesting that increased HAT activity only
partly accounts for the mechanisms by which cbp induction by DR
increases lifespan. Since cbp-1 RNAi also blocks effects of bDR on
expression of genes regulating metabolic pathways, we hypothesize
that the protective effect of CBP is mediated through these
metabolic effects, particularly through a shift from glycolysis to
fatty acid oxidation [14], as previously reported [42] (SOD
isoforms do not appear to play a role in lifespan extension with at
least some protocols of DR [43]). Since glucose produces a
transcriptional profile opposite that of DR [14], these studies also
suggest that down-regulation of the same CBP transcriptional
complex implicated here may play a role in the development of
age-related diseases such as Huntington’s disease [44], Alzheimer’s
disease, and diabetic complications.
Material and Methods
Mouse Gene Expression
All studies in mice were carried out with permission and in
accordance with the Institutional Animal Care and Use Commit-
tee at Mount Sinai School of Medicine. Ten-week-old male mice
(n=10 mice per strain) were obtained from Jackson Laboratory.
The strains, with average lifespans as reported [12,13], were as
follows (mean lifespan 6 standard error in days): BALB/cByJ
(648620.6); A/J (662620.4); C3H/HeJ (700635); DBA/2J
(722630); C57Bl/6J (827630). Animals were housed with free
access to food and water under a 12:12 h light-dark cycle (lights on
at 7:00 am). Mice were sacrificed, following a balanced design
during the light period (10:00 am to 2:00 pm), by decapitation
after a brief exposure to carbon dioxide. Hypothalamic tissue was
quickly dissected, frozen on dry ice, and stored at 270uC until
extraction of RNA. Primer and normalization sequence are given
in the supplementary information.
C. elegans and RNAi Strains
N2, rrf3 (pk1426), daf-2 (e1370), daf-16 (m26), eat-2 (ad1113),
CL2006 [26], glp-1 (e2141), clk-1 (e2519), mev-1 (kn-1), and sod-
3::GFP transgenic (CF1553) worm strains were obtained from the
Caenorhabditis Genetics Center (Minneapolis, MN). Worms were
grown at 20uC unless described otherwise. cbp-1, daf-16, hsf-1, and
dev-1 dsRNA expressing bacterial strains were from the genomic
RNAi library (produced by J. Ahringer at the Wellcome/CRC
Institute). The bacterial strain containing empty vector L4440 was
used as the control. RNAi was carried out following standard
bacterial feeding methods [45]. All RNAi experiments were
performed only in adult worms.
Protocols for Dietary Restriction
Bacterial dilution. Bacteria concentration was obtained by
measuring OD600. The relation between OD600 and bacte-
ria concentration was determined by colony formation
assay (BC=OD600/0.0121610ˆ7 cells/ml). After obtaining
concentration of each culture, control or RNAi bacteria was re-
suspended in S basal media supplemented with flurodeoxyuridine
(FUDR) (0.1 g/L), ampicillin (0.1 g/L), and IPTG (0.24 g/L) to
make concentrations of 10ˆ8, 10ˆ9, and 10ˆ10 cells/ml. Lifespan
study was performed at each dilution.
Axenic media. The liquid axenic media [16] consisted of 3%
Soy Peptone, 3% Yeast Extract, 0.05% Hemoglobin, and 94%
water, supplemented with FUDR(0.1 g/L)and ampicillin(0.1 g/L).
Adult worms were grown on solid plates with appropriate RNAi or
control constructs for 5 d, then transferred to liquid axenic media, or
to control agar ad-lib plates with no RNAi, and scored every 2 d.
Lifespan Analysis
Eggs were collected by standard hypochlorite treatment of gravid
worms. Worms were grown on 100 mm NGM plates until the L4/
early adult stage was reached. The worms were then transferred to
35 mm NGM plates supplemented with 5-FUDR (0.1 g/ml) with 10
worms on each plate. The worms were scored every 2 d and were
categorized as dead when they failed to respond to gentle prodding
from a platinum wire. For bacterial dilution, bacteria containing
dsRNA or empty vector were suspended in S basal medium
supplemented with FUDR (0.1 g/L), ampicillin (0.1 g/L), and IPTG
(0.24 g/L) at the concentrations of 10ˆ8, 10ˆ9, or 10ˆ10 cells/ml.
The worms were transferred to 24 well plates with 15 worms per well
and scored every 2 d. For studies in liquid axenic media, adult worms
were grown on RNAi or control solid media plates for 5 d, then
transferred to liquid axenic media afterward and scored every 2 d.
RNAi Screening
RNAi screening was carried out using 24 well plates. E. coli
expressing various dsRNAs were prepared at the concentration of
10ˆ9 cells/ml. The synchronized rrf3 worms just reaching
adulthood were washed off agar plates and suspended in M9
buffer. Around 25 worms were pipetted into each E. coli solution.
On day 15 and day 20, the number of dead worms was counted.
Genes whose inhibition by RNAi reduced the number of live
worms at day 20 (according to visual inspection) were further
assessed in more detailed lifespan assays; only four genes out of
more than 500 tested met this initial criterion, and lifespan
reducing effects were corroborated for all four.
Paraquat Assay
Thirty worms from each experimental group were transferred
into 50 ul of a 50 mM paraquat solution with 10 worms per well
in a 96 well plate. Worms were scored every 24 h and were
categorized as dead when they failed to respond to gentle prodding
from a platinum wire.
Paralysis Assay
The paralysis assay followed the method described by Cohen
et al [46]. Briefly, 50 worms were placed on plates or in wells (10
worms per plate or well). The worms were tested daily by tapping
the head with a platinum wire. Worms that moved their heads but
failed to move their bodies were categorized as paralyzed. To
avoid scoring of dead animals as paralyzed, paralysis assay was
terminated at day 12 of adulthood unless described otherwise.
RNA Isolation and Quantitative Real-Time PCR (q-PCR)
Total RNA was isolated from synchronized populations at day 7
of adult worms. Total RNA was extracted using TRIzol reagent
(Invitrogen, 15596-018). 1 ug total RNA from each sample was
converted into cDNA with 100 pg utilized for each individual
q-PCR assay in a 40 cycle, three-step PCR reaction using the ABI
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module and robot arm. Amplification was performed in 20 mM
Tris pH 8.4, 3 mM MgCl2, 200 mM dNTPs, 0.5% SYBR green
(Molecular Probes), 200 uM of each primer, and 0.25 U platinum
Taq (Life Technologies). Quantification was completed using














Normalization gene-mouse tubulin alpha 1 (BC002219)
forward: 59-TGCCTTTGTGCACTGGTATG-39
reverse: 59-CTGGAGCAGTTTGACGACAC-39
































50–100 worms from each experimental group were boiled in
20 ul 2X sample buffer for 20 min. After 5 min chilling on ice, the
whole sample was loaded onto SDS-PAGE for immunoblotting.
Equal loading was assured as the same number of worms was used
in each experiment. Antibodies CBP (C-1): Sc-7300 and DAF-16
(ce-300): Sc-33738 were purchased from Santa Cruz Biotechnol-
ogy Inc. Anti-Histone H4 (#07-108) and anti-H4 (Lys5) (07-327)
were purchased from Upstate. Immunoblots were carried out
following standard procedures (Dilutions: anti-CBP antibody
1:200, anti-DAF-16 antibody 1:500, anti-H4 antibody 1:3000,
and anti-H4 (Lys5) antibody 1:2000).
Drug Treatments
TSA (#19-138) was purchased from Upstate and prepared at a
concentration of 150 ng/ul. Sodium butyrate (NaB) was obtained
from Sigma and prepared at the concentration from 2, 5, or
10 mM. The drug solution was added onto seeded plates and
distributed evenly on the surface of the agar. Worms just reaching
adulthood were transferred to the plates with or without drugs and
lifespan or paralysis assay was conducted as described above.
Aging Phenotype Studies
To assess autofluorescence, 6–10 N2 worms from each
experiment group were transferred onto a slide and images were
taken by fluorescence microscope. Green fluorescence intensity of
each worm was measured using software image-J. For movement
studies, adult worms that only moved head or tail but failed to
move the body upon prodding were considered as immobile and
the number of immobile worms was counted daily. The ability to
swim in water was quantified as the number of full movement back
and forth within 30 s. To assess egg laying, two worms were placed
onto a seeded NGM plate and were transferred daily to fresh
plates. The number of eggs left on the plate was counted daily.
Ten plates were used for each experiment group.
Statistical Analysis
Analysis of lifespan began with an estimation of the survival
curve using the Kaplan-Meier product limit estimate of the
survivorship function. The Gompertz variables G and A were
calculated using non-linear regression on the Kaplan-Meier
estimates of the survivorship curves; although another parameter,
M0, can be included in such an analysis, we have found that this
parameter is essentially 0 when included in the analysis [24] and is
therefore not included. After the non-linear regression determined
the values for G, the extra sum-of-squares F-test was used to assess
significant effects on G values. The analysis was completed using
Prism 4 software. For survival studies, statistical significance was
determined using Log-rank test. For paraquat studies, paralysis
assays, and q-PCR, statistical significance was determined using
t-tests. For mouse gene expression studies, linear regression was
used to determine the correlation between mRNA levels and
average lifespan across the five strains of mice.
Supporting Information
Figure S1 Bacterial dilution extended lifespan in C.
elegans. E. coli was prepared at 5*10ˆ7, 10ˆ8, 2*10ˆ8, 5*10ˆ8,
10ˆ9, 2*10ˆ9, 5*10ˆ9, and 10ˆ10 cells/ml and average lifespan
of the rrf3 worms was measured.
Found at: doi:10.1371/journal.pbio.1000245.s001 (2.58 MB
DOC)
Figure S2 cbp-1 RNAi does not affect the p-pumping
rate in N2 worms. Data are quantified as the number of
pharyngeal pumping within 15 s and presented as mean 6 SEM
(n=6–10/group).
Found at: doi:10.1371/journal.pbio.1000245.s002 (2.77 MB
DOC)
Figure S3 cbp-1 RNAi does not affect egg laying in N2
worms. Data are quantified as the number of eggs per day per
two worms and presented as mean 6 SEM (n=10/group).
Found at: doi:10.1371/journal.pbio.1000245.s003 (2.67 MB
DOC)
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worms were grown at optimum bacterial concentration and fed
with either control bacteria (L4440) or bacteria expressing cbp-1
dsRNA for 7 d. The neuron-specific dye DiI was added into the
culture and worms were stained for 2 h. Images were taken by
confocal microscope using a 40X objective lens. Red staining:
amphid neurons.
Found at: doi:10.1371/journal.pbio.1000245.s004 (6.62 MB
DOC)
Figure S5 cbp-1 and daf-16 RNAi similarly block the
induction of sod-3 by the daf-2 mutation. sod-3::GFP
transgenic worms (CF1553) were fed with daf-2 dsRNA alone
(A), daf-2 and cbp-1 dsRNA (B), daf-2 and daf-16 dsRNA (C), or
control L4440 empty vector (D) at 20 C, and photographed by
fluorescence microscope. RNAi dilution effect was controlled by
1:1 dilution of daf-2 RNAi with L4440. (E) cbp-1 RNAi and daf-16
RNAi equally decreased sod-3 expression. Average GFP fluores-
cence was quantified using software imageJ and difference
between groups was determined by student’s t-test (*p,0.05,
n=5–7/group).
Found at: doi:10.1371/journal.pbio.1000245.s005 (4.72 MB
DOC)
Figure S6 Overexpression of cbp-1 does not extend
lifespan in N2 worms at 25uC. Transgenic worms were
generated by co-microinjecting PCR product cbp-1::cbp-1 and rol-6
plasmid (pRF4) into N2 worms. Two independent transgenic lines
were maintained and used in lifespan assay. Control worms were
generated by injecting rol-6 plasmid alone. No lifespan extension
was observed by cbp-1 overexpression (p=0.11 line 1 versus
control, p=0.14 line 2 versus control).
Found at: doi:10.1371/journal.pbio.1000245.s006 (2.65 MB
DOC)
Figure S7 cbp-1 RNAi increases, rather than reverses,
increased Nile Red staining produced by the daf-2
mutation. daf-2 mutant worms were fed with control bacteria
or bacteria expressing cbp-1 dsRNA for 5 d at 25uC. Worms were
stained with Nile Red dye and fluorescence was quantified
software ImageJ. Data are presented as mean 6 SEM (n=5/
group, p,0.05).
Found at: doi:10.1371/journal.pbio.1000245.s007 (2.58 MB
DOC)
Figure S8 cbp-1 RNAi blocks the inhibition of F47G4.3,
an ortholog of mammalian glycerophosphate dehydro-
genase, by bDR. Data are presented as mean 6 SEM (*p,0.05,
n=4–6/group).
Found at: doi:10.1371/journal.pbio.1000245.s008 (2.81 MB
DOC)
Figure S9 cbp-1 RNAi blocks the induction of ZK370.5,
an ortholog of mammalian pyruvate dehydrogenase
kinase, by bDR. Data are presented as mean 6 SEM
(*p,0.05, n=4–6/group).
Found at: doi:10.1371/journal.pbio.1000245.s009 (2.74 MB
DOC)
Table S1 Summary of lifespan assays.
Found at: doi:10.1371/journal.pbio.1000245.s010 (0.18 MB
DOC)
Table S2 Gompertz values for lifespan assays.
Found at: doi:10.1371/journal.pbio.1000245.s011 (0.04 MB
DOC)
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